Latest news
Trastuzumab Rezetecan Improves Progression-Free Survival in HER2-Positive Metastatic Breast Cancer - The ASCO PostThe ASCO Post · Fri, 07 Aug 2026 14:42:22 GMTHRR-Altered Metastatic Prostate Cancer Talazoparib Plus Enzalutamide Improves Progression-Free Survival - The ASCO PostThe ASCO Post · Thu, 06 Aug 2026 14:00:43 GMTLong-Term OMNIVORE Data Show Durable Treatment-Free Survival After Nivolumab in Advanced RCC - OncLiveOncLive · Thu, 06 Aug 2026 12:18:02 GMTMesothelioma Patient Remains Cancer-Free Two Years After Single CAR T Cell Treatment - Mesothelioma.netMesothelioma.net · Wed, 05 Aug 2026 15:29:01 GMTAdAlta reports two year cancer free survival after single dose of experimental mesothelioma therapy - BiotechDispatchBiotechDispatch · Wed, 05 Aug 2026 09:32:35 GMTIntravesical Pirarubicin After UTUC Surgery May Prolong Relapse-Free Survival - Renal and Urology NewsRenal and Urology News · Mon, 03 Aug 2026 04:00:00 GMTELEVATE Trial Shows Disease-Free Survival Benefit With Adjuvant Ensartinib in ALK-Positive NSCLC - The ASCO PostThe ASCO Post · Tue, 28 Jul 2026 14:29:40 GMTDabrafenib Plus Trametinib Improves Progression-Free Survival in BRAF V600E-Positive Differentiated Thyroid Cancer - The ASCO PostThe ASCO Post · Mon, 27 Jul 2026 14:48:53 GMT